Continuing Medical Education Information

The American Society of Clinical Oncology (ASCO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The live activity has been approved for a maximum of 15.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All nonphysician attendees are welcome to submit a request for a Certificate of Participation, through the submission process, which may enable nonphysicians to apply their participation toward re-licensure. Please note, however, that all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits were submitted

Any questions related to CME may be directed to ASCO Staff at cme@asco.org.

Tutorial Feedback and Certificates

Every participant is encouraged to submit a Tutorial Feedback Form, provide session ratings, and access certificates for the Tutorial. Your feedback is utilized by leadership to enhance programs, develop new initiatives, gauge educational impact, and plan for future educational activities.

  • To give overall feedback on the Tutorial
  1. Submit a Tutorial  Feedback Form
  •  To provide feedback on a specific session
  1. Visit the CME Portal
  2. Select a session by searching by time or track
  3. Rate the session and leave a comment about how we can improve
  •  To access certificates and claim CME credit
  1. Visit the CME Portal
  2. Select a session by searching by time or keyword
  3. Select “Claim More Credits” to claim CME credits and access your CME Certificate or Certificate of Participation

Certificates of Attendance

Attendees can download a Certificate of Attendance from the CME Portal if they need a record of their attendance at the Tutorial but do not require documentation for continuing education purposes. Please note that this certificate does not award any AMA PRA Category 1 Credit™.

Feedback and CME credit requests are due by June 6, 2016.

Needs Statement

The Markers in Cancer Diagnostic Development Tutorial is a joint effort between ASCO, EORTC and NCI to provide a comprehensive training for early-career scientists and clinicians who are or wish to be actively engaged in cancer biomarker test development.  By addressing the educational needs of these researchers, there is the potential to influence the pace and quality of research in cancer biomarkers, contributing ultimately to a more personalized treatment approach for patients with cancer. 

Target Audience

The Tutorial is designed for early-career individuals who are actively engaged in biomarker test development, and provides in-depth, case-based training on the scientific and regulatory aspects of biomarker test development. 

Learning Objectives

Upon participation in this activity, attendees will be able to:

  • Compare and contrast the strength of potential hypotheses and relevant endpoints to evaluate cancer biomarkers in a variety of clinical use cases
  • Explain the importance of standardization of assay procedures early in the development process, to include characterization of both the analytic and clinical performance of the assay
  • Apply statistical principles to guide the development of single analyte and multiplex tests
  • Distinguish the clinical trial study design process for evaluating a cancer biomarker from the design process for evaluating the efficacy of a therapeutic agent
  • Outline the regulatory options and requirements (US and European) to bring new cancer biomarkers to market

This activity was planned in the context of the following ACGME competencies: Medical knowledge; Practice-based learning and improvement.

Disclaimer and Unlabeled Usage Statement

The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Tutorial Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.

Collaborating Organizations